| 产品详情 |
| Edit |   |
|---|
| Product Name | LFM-A13 |
|---|
| Description | FM-A13 is a selective inhibitor of Bruton's tyrosine kinase (BTK) - IC50's = 2.5 µM (recombinant BTK) and 17.2 µM (human BTK). It has also been shown to inhibit Polo-like kinase (PLK) (IC50 = 61 µM for human PLK3). It displays no activity (concentrations up to 278 µM) at JAK1, JAK3, HCK, EGFRK and IRK2 or CDK1-3, CHK1, IKK, MAPK1, SAPK2a and ten tyrosine kinases. MW: 360. Purity ≥98% by TLC |
|---|
| Size | 5 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | (2Z) -2-Cyano-N-(2,5-dibromophenyl)-3-hydroxy-2-butenamide |
|---|
| Gene, Accession, CAS # | CAS: 244240-24-2 |
|---|
| Catalog # | 2414-5 |
|---|
| Price | |
|---|
| Order / More Info | LFM-A13 from BIOVISION, INC. |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|